000 01337cam a2200289 a 4500
001 vtls003227429
003 MY-SjTCS
005 20200306154303.0
008 111206s2010 nyu b 001 0 eng
020 _a9781616689773 (pbk.)
039 9 _a201203141600
_bshuhada
_c201203141600
_dshuhada
_c201203131752
_dshuhada
_c201203131746
_dshuhada
_y201112061109
_zmasrina
082 0 4 _a615.71
_bCHI 2010
100 1 _aChirkov, Yuliy Y.
_958217
245 1 0 _aBeneficial effects of perhexiline in cardiovascular disease states /
_cYuliy Y. Chirkov, Aaron L. Sverdlov, and John D. Horowitz.
260 _aNew York. :
_bNova Biomedical/Nova Science Publishers,
_c2010.
300 _aviii, 43 p. ;
_c22 cm.
490 1 _aCardiology research and clinical developments
504 _aIncludes bibliographical references (p. [31]-38) and index.
505 0 _aClinical applications of perhexiline -- Pharmacokinetics and toxicity of perhexiline -- Pharmacology of perhexiline -- Conclusion and future perspectives.
650 0 _aCardiovascular agents.
_927134
650 0 _aPerhexiline
_xTherapeutic use.
_9209648
650 0 _aAngina pectoris
_xChemotherapy.
_958218
700 1 _aSverdlov, Aaron L.
_958219
700 1 _aHorowitz, John D.
_958220
830 0 _aCardiology research and clinical developments series.
_959876
920 _aPHA : 177442
999 _c26999
_d26999